Anty-VEGF |
vascular endothelial growth factor inhibitor |
BCVA |
best corrected visual acuity |
CRT |
central foveal thickness |
DCP |
deep capillary plexus |
DD |
disc diameter |
DME |
diabetic macular edema |
DR |
diabetic retinopathy |
DRIL |
disorganization of retinal inner layers |
EDTA |
ethylenediaminetetraacetic acid |
ETDRS |
Early Treatment Diabetic Retinopathy Study |
FA |
fluorescein angiography |
FAZ |
foveal avascular zone |
HbA1c |
glycated hemoglobin |
HPLC |
high-performance liquid chromatography |
ILM |
internal limiting membrane |
IRMA |
intraretinal microvascular abnormalities |
MAs |
microaneurysms |
Max RT |
maximum retinal thickness |
MCP |
middle capillary plexus |
NGSP |
National Glycohemoglobin Standardization Program |
NVD |
neovascularization at the disc |
NVE |
neovascularization elsewhere |
OCT |
optical coherence tomography |
OCTA |
optical coherence tomography angiography |
OGTT |
oral glucose tolerance test |
SCP |
superficial capillary plexus |
SD-OCT |
spectral domain optical coherence tomography |
SRF |
subretinal fluid |
SSADA |
split spectrum amplitude decorrelation angiography |
SSI |
signal strength index |
VD |
vessel density |
VEGF |
vascular endothelial growth factor |